EyePoint Pharmaceuticals, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
EYPT Nasdaq 2830 eyepointpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for EyePoint Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Nov 9th, 2025 5:04 am
EyePoint Pharmaceuticals Inc (EYPT) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... - Nov 7th, 2025 2:00 am
EyePoint Pharmaceuticals (EYPT): Forecast 61.3% Revenue Growth Tests Premium Valuation, Ongoing Losses - Nov 6th, 2025 2:17 pm
EyePoint (EYPT) Q3 2025 Earnings Call Transcript - Nov 5th, 2025 3:06 pm
EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates - Nov 5th, 2025 6:15 am
EyePoint Pharmaceuticals: Q3 Earnings Snapshot - Nov 5th, 2025 5:22 am
EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments - Nov 5th, 2025 5:00 am
EyePoint Announces Participation at Upcoming Investor Conferences - Nov 3rd, 2025 5:00 am
With 57% institutional ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a favorite amongst the big guns - Oct 30th, 2025 4:17 am
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - Oct 29th, 2025 5:00 am
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Oct 16th, 2025 5:00 am
EyePoint Announces Pricing of Public Offering - Oct 14th, 2025 8:43 pm
EyePoint Announces Proposed Public Offering of Common Stock - Oct 14th, 2025 2:35 pm
EyePoint Announces Pivotal Phase 3 Program Initiation for DURAVYU™ in Diabetic Macular Edema - Oct 14th, 2025 2:01 pm
Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - Sep 25th, 2025 7:29 am
Biotech Stocks Rally. 3 Favorite Plays From the Charts. - Sep 23rd, 2025 11:13 am
Is EyePoint Pharmaceuticals (NASDAQ:EYPT) In A Good Position To Invest In Growth? - Sep 19th, 2025 4:11 am
Analysts Have Lowered Expectations For EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) After Its Latest Results - Aug 9th, 2025 6:26 am
EyePoint Pharmaceuticals (EYPT) Reports Q2 Loss, Misses Revenue Estimates - Aug 6th, 2025 6:30 am
EyePoint to Present at the H.C. Wainwright 5th Annual Ophthalmology Virtual Conference - Aug 6th, 2025 5:30 am